StonvexLoading…
StonvexStonvexStonvexCore line items from GATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $609.95M | $583.70M | $1.74B | $1.29B | $852.10M |
Operating Income | Not available | $79.50M | $279.10M | $209.20M | $150.60M |
Net Income | Not available | $85.50M | $333.30M | $236.30M | $154.10M |
EPS (Diluted) | $2.56 | $2.35 | $9.12 | $6.46 | $4.21 |
Total Assets | Not available | $17.94B | $18.00B | $13.31B | $13.20B |
Total Liabilities | Not available | $14.29B | $14.36B | $10.59B | $10.53B |
Cash & Equivalents | Not available | $740.90M | $743.00M | $696.10M | $754.60M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 35.50M | 35.40M | 35.68M | 35.64M |